Russell Booth Hall to Pemphigus
This is a "connection" page, showing publications Russell Booth Hall has written about Pemphigus.
Connection Strength
2.981
-
Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus. J Invest Dermatol. 2021 12; 141(12):2858-2865.e4.
Score: 0.804
-
Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab. PLoS One. 2020; 15(6):e0233957.
Score: 0.751
-
Cost of Inpatient Care of Patients With Pemphigus in the United States: Translating Dollars and Cents Into Improved Patient Care. JAMA Dermatol. 2016 06 01; 152(6):629-30.
Score: 0.567
-
A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone. Br J Dermatol. 2015 Mar; 172(3):760-8.
Score: 0.518
-
Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Br J Dermatol. 1999 Jun; 140(6):1079-86.
Score: 0.175
-
Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis. PLoS One. 2018; 13(9):e0198074.
Score: 0.167